Galectin Therapeutics Inc. (GALT)
NASDAQ: GALT · Real-Time Price · USD
2.320
-0.050 (-2.11%)
Apr 28, 2026, 4:00 PM EDT - Market closed
Galectin Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Apr '26 Apr 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Market Capitalization | 153 | 268 | 81 | 103 | 67 | 123 | |
| Market Cap Growth | 79.04% | 231.27% | -21.14% | 52.89% | -45.33% | -3.92% | |
| Enterprise Value | 273 | 385 | 163 | 147 | 84 | 109 | |
| Last Close Price | 2.32 | 4.16 | 1.29 | 1.66 | 1.13 | 2.07 | |
| PB Ratio | - | -2.12 | -0.79 | -1.70 | -2.09 | 46.96 | |
| P/TBV Ratio | - | - | - | - | - | 335.62 | |
| Debt / Equity Ratio | -1.09 | -1.09 | -1.03 | -1.19 | -1.24 | 11.11 | |
| Net Debt / Equity Ratio | -0.95 | -0.95 | -0.89 | -0.77 | -0.66 | -4.05 | |
| Quick Ratio | 2.21 | 2.21 | 0.43 | 1.64 | 1.43 | 4.39 | |
| Current Ratio | 2.42 | 2.42 | 0.49 | 1.77 | 1.58 | 4.63 | |
| Return on Equity (ROE) | - | - | - | - | - | -227.74% | |
| Return on Assets (ROA) | -67.81% | -67.81% | -116.08% | -96.17% | -75.96% | -52.81% | |
| Return on Capital Employed (ROCE) | -174.60% | -174.60% | 236.90% | -304.00% | -463.60% | -92.00% | |
| Earnings Yield | -20.28% | -11.50% | -58.11% | -40.00% | -57.74% | -24.85% | |
| Buyback Yield / Dilution | -2.56% | -2.56% | -3.57% | -1.29% | -1.48% | -2.63% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.